- R&D 100 Awards
Thursday, November 15, 11:15 - 12:00 PM
Speaker(s): Anthony Frutos, PhD
Room #: Madison
Two-dimensional or 2D cell culture models have been utilized for decades in the process of drug discovery and development due to their ease of use and established compatibility with high throughput screening techniques. In the last several years, however, three-dimensional or 3D cell culture models and tools have emerged that are increasingly being adopted by pharmaceutical and biotechnology companies because of the growing body of evidence showing better correlation of these systems to in vivo results.
These 3D models range from relatively simple 3D spheroids to more complex organoids and organ/body-on-a-chip technologies, and they are impacting a variety of fields including oncology drug screening, early assessment of compound/drug safety testing as well as tissue engineering. This presentation will give an overview of some of the exciting advances in the field of 3D cell culture and—through a series of case studies—highlight several of the new, enabling tools facilitating the adoption of 3D cell techniques.